You are here

  • Home
  • Archive
  • Volume 73, Issue 5
  • Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

Article metrics

Article menu
Hepatology
Original research
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes

 

Online download statistics by month:

Online download statistics by month: January 2024 to November 2024

AbstractFullPdf
Jan 202427322648759
Feb 202437923756732
Mar 202422982295362
Apr 202424102402513
May 202410271004364
Jun 2024882876262
Jul 2024684681186
Aug 2024674658166
Sep 2024842828164
Oct 2024895894163
Nov 2024733722130
Total16969167643801